Skip to main content
Top
Published in: Nutrition & Metabolism 1/2009

Open Access 01-12-2009 | Brief communication

Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes

Authors: Hajime Haimoto, Tae Sasakabe, Kenji Wakai, Hiroyuki Umegaki

Published in: Nutrition & Metabolism | Issue 1/2009

Login to get access

Abstract

We previously demonstrated that a loosely restricted 45%-carbohydrate diet led to greater reduction in hemoglobin A1c (HbA1c) compared to high-carbohydrate diets in outpatients with mild type 2 diabetes (mean HbA1c level: 7.4%) over 2 years. To determine whether good glycemic control can be achieved with a 30%-carbohydrate diet in severe type 2 diabetes, 33 outpatients (15 males, 18 females, mean age: 59 yrs) with HbA1c levels of 9.0% or above were instructed to follow a low-carbohydrate diet (1852 kcal; %CHO:fat:protein = 30:44:20) for 6 months in an outpatient clinic and were followed to assess their HbA1c levels, body mass index and doses of antidiabetic drugs. HbA1c levels decreased sharply from a baseline of 10.9 ± 1.6% to 7.8 ± 1.5% at 3 months and to 7.4 ± 1.4% at 6 months. Body mass index decreased slightly from baseline (23.8 ± 3.3) to 6 months (23.5 ± 3.4). Only two patients dropped out. No adverse effects were observed except for mild constipation. The number of patients on sulfonylureas decreased from 7 at baseline to 2 at 6 months. No patient required inpatient care or insulin therapy. In summary, the 30%-carbohydrate diet over 6 months led to a remarkable reduction in HbA1c levels, even among outpatients with severe type 2 diabetes, without any insulin therapy, hospital care or increase in sulfonylureas. The effectiveness of the diet may be comparable to that of insulin therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, Yancy WS, Phinney SD: Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007, 86 (2): 276-284. Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, Yancy WS, Phinney SD: Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007, 86 (2): 276-284.
2.
go back to reference Accurso A, Bernstein RK, Dahlqvist A, Draznin B, Feinman RD, Fine EJ, Gleed A, Jacobs DB, Larson G, Lustig RH: Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab. 2008, 5: 9-16. 10.1186/1743-7075-5-9.CrossRef Accurso A, Bernstein RK, Dahlqvist A, Draznin B, Feinman RD, Fine EJ, Gleed A, Jacobs DB, Larson G, Lustig RH: Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab. 2008, 5: 9-16. 10.1186/1743-7075-5-9.CrossRef
3.
go back to reference Gannon MC, Nuttall FQ: Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes. 2004, 53 (9): 2375-2382. 10.2337/diabetes.53.9.2375.CrossRef Gannon MC, Nuttall FQ: Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes. 2004, 53 (9): 2375-2382. 10.2337/diabetes.53.9.2375.CrossRef
4.
go back to reference Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP: Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 2005, 142 (2): 403-411.CrossRef Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP: Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 2005, 142 (2): 403-411.CrossRef
5.
go back to reference Nielsen JV, Joensson E: Low-carbohydrate diet in type 2 diabetes: Stable improvement of bodyweight and glycemic control during 22 months follow-up. Nutr Metab (Lond). 2006, 3: 22-26. 10.1186/1743-7075-3-22.CrossRef Nielsen JV, Joensson E: Low-carbohydrate diet in type 2 diabetes: Stable improvement of bodyweight and glycemic control during 22 months follow-up. Nutr Metab (Lond). 2006, 3: 22-26. 10.1186/1743-7075-3-22.CrossRef
6.
go back to reference Dashti HM, Mathew TC, Khadada M, Al-Mousawi M, Talib H, Asfar SK, Behbahani AI, Al-Zaid NS: Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem. 2007, 302 (2): 249-256. 10.1007/s11010-007-9448-z.CrossRef Dashti HM, Mathew TC, Khadada M, Al-Mousawi M, Talib H, Asfar SK, Behbahani AI, Al-Zaid NS: Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem. 2007, 302 (2): 249-256. 10.1007/s11010-007-9448-z.CrossRef
7.
go back to reference Westman EC, Yancy WS, Mavropoulos JC, Marquart M, McDuffie JR: The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond). 2008, 5: 36-44. 10.1186/1743-7075-5-36.CrossRef Westman EC, Yancy WS, Mavropoulos JC, Marquart M, McDuffie JR: The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond). 2008, 5: 36-44. 10.1186/1743-7075-5-36.CrossRef
8.
go back to reference Haimoto H, Iwata M, Wakai K, Umegaki H: Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: A 2-year follow-up study. Diabetes Res Clin Pract. 2008, 79 (2): 350-356. 10.1016/j.diabres.2007.09.009.CrossRef Haimoto H, Iwata M, Wakai K, Umegaki H: Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: A 2-year follow-up study. Diabetes Res Clin Pract. 2008, 79 (2): 350-356. 10.1016/j.diabres.2007.09.009.CrossRef
9.
go back to reference Tanaka K, Moriya T, Kanamori A, Yajima Y: Analysis and a long-term follow up of ketosis-onset Japanese NIDDM patients. Diabetes Res Clin Pract. 1999, 44 (2): 137-146. 10.1016/S0168-8227(99)00023-6.CrossRef Tanaka K, Moriya T, Kanamori A, Yajima Y: Analysis and a long-term follow up of ketosis-onset Japanese NIDDM patients. Diabetes Res Clin Pract. 1999, 44 (2): 137-146. 10.1016/S0168-8227(99)00023-6.CrossRef
10.
go back to reference Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B: Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006, 29 (9): 1963-1972. 10.2337/dc06-9912.CrossRef Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B: Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006, 29 (9): 1963-1972. 10.2337/dc06-9912.CrossRef
11.
go back to reference Kobayashi M, Yamazaki K, Hirao K, Oishi M, Kanatsuka A, Yamauchi M, Takagi H, Kawai K: Diabetes Clinical Data Management Study Group, The status of diabetes control and antidiabetic drug therapy in Japan-A cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1). Diabet Res Clin Pract. 2006, 73 (2): 198-204. 10.1016/j.diabres.2006.01.013.CrossRef Kobayashi M, Yamazaki K, Hirao K, Oishi M, Kanatsuka A, Yamauchi M, Takagi H, Kawai K: Diabetes Clinical Data Management Study Group, The status of diabetes control and antidiabetic drug therapy in Japan-A cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1). Diabet Res Clin Pract. 2006, 73 (2): 198-204. 10.1016/j.diabres.2006.01.013.CrossRef
12.
go back to reference Daly ME, Paisey R, Paisey R, Millward BA, Eccles C, Williams K, Hammersley S, Macleod KM, Gale TJ: Short-term effects of severe dietary carbohydrate-restriction advice in Type 2 diabetes – a randomized controlled trial. Diabet Med. 2006, 23 (1): 15-20. 10.1111/j.1464-5491.2005.01760.x.CrossRef Daly ME, Paisey R, Paisey R, Millward BA, Eccles C, Williams K, Hammersley S, Macleod KM, Gale TJ: Short-term effects of severe dietary carbohydrate-restriction advice in Type 2 diabetes – a randomized controlled trial. Diabet Med. 2006, 23 (1): 15-20. 10.1111/j.1464-5491.2005.01760.x.CrossRef
13.
go back to reference Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S: A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003, 348 (21): 2082-2090. 10.1056/NEJMoa022207.CrossRef Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S: A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003, 348 (21): 2082-2090. 10.1056/NEJMoa022207.CrossRef
14.
go back to reference Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L: A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003, 348 (21): 2074-2081. 10.1056/NEJMoa022637.CrossRef Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L: A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003, 348 (21): 2074-2081. 10.1056/NEJMoa022637.CrossRef
Metadata
Title
Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes
Authors
Hajime Haimoto
Tae Sasakabe
Kenji Wakai
Hiroyuki Umegaki
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2009
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-6-21

Other articles of this Issue 1/2009

Nutrition & Metabolism 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine